Frailty Study of Older Adults Getting Chemotherapy and Radiation Therapy
The investigators hypothesize that frailty assessment prior to concurrent chemotherapy and radiation therapy in the elderly will predict treatment-related toxicity and morbidity and that such assessment at serial time points will help improve treatment and outcomes for these patients.
Cancer
Change in frailty assessment due chemotherapy toxicity, Validated frailty measures, and geriatric assessment tools will be used., Subjects will be followed for frailty measures during standard of care chemotherapy treatment, an average of 8 weeks per treatment
The investigators hypothesize that frailty assessment prior to concurrent chemotherapy and radiation therapy in the elderly will predict treatment-related toxicity and morbidity and that such assessment at serial time points will help improve treatment and outcomes for these patients.